BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6975318)

  • 1. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.
    Gillis S; Scheid M; Watson J
    J Immunol; 1980 Dec; 125(6):2570-8. PubMed ID: 6968790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.
    Kasahara T; Mukaida N; Hatake K; Motoyoshi K; Kawai T; Shiori-Nakano K
    J Immunol; 1985 Mar; 134(3):1682-9. PubMed ID: 3871456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
    Schwyzer M; Fontana A
    J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OT-CLL: a human T cell chronic lymphocytic leukemia that produces IL 2 in high titer.
    Friedman SM; Thompson G; Halper JP; Knowles DM
    J Immunol; 1982 Feb; 128(2):935-40. PubMed ID: 6976389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
    Gillis S; Smith KA; Watson J
    J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The purification and properties of human T cell growth factor.
    Mier JW; Gallo RC
    J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells.
    Brown WC; Grab DJ
    J Immunol; 1985 Nov; 135(5):3184-90. PubMed ID: 3930599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
    Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
    J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and biologic characterization of lymphocyte regulatory molecules. IV. Purification of Interleukin 2 from a murine T cell lymphoma.
    Mochizuki D; Watson J; Gillis S
    J Immunol; 1980 Dec; 125(6):2579-83. PubMed ID: 7000903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization and purification of human B cell stimulatory factor (BSF).
    Schwarting R; Welte K; Chiorazzi N; Ralph P; Lane CL; Long C; Wang CY
    Eur J Immunol; 1985 Jun; 15(6):632-7. PubMed ID: 3874076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro synthesis of interleukin 2 (IL-2) by T lymphocytes extracted from a lymphoepithelial thymoma. Purification and biochemical characterization].
    Ponzoni M; Fenice M; Montaldo P; Tonini GP; Cornaglia-Ferraris P
    Boll Ist Sieroter Milan; 1985; 64(1):12-24. PubMed ID: 3873951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoma production of T cell growth factor (Interleukin 2).
    Farrar JJ; Fuller-Farrar J; Simon PL; Hilfiker ML; Stadler BM; Farrar WL
    J Immunol; 1980 Dec; 125(6):2555-8. PubMed ID: 6968789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive interleukin 2 production by the JURKAT human leukemic T cell line.
    Pawelec G; Borowitz A; Krammer PH; Wernet P
    Eur J Immunol; 1982 May; 12(5):387-92. PubMed ID: 6980126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial purification and characterization of a BCGFII from EL4 culture supernatants.
    Dutton RW; Wetzel GD; Swain SL
    J Immunol; 1984 May; 132(5):2451-6. PubMed ID: 6609198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of a surface antigen expressed on activated human thymus-derived lymphocytes.
    Udey MC; Jendrisak MD; Parker CW
    J Immunol; 1982 Apr; 128(4):1870-5. PubMed ID: 6801123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and biochemical characterization of human lymphocyte mitogenic factor (LMF).
    Rutenberg WD; al-Khalidi U; Rosen FS; Merler E
    J Immunol; 1979 Feb; 122(2):723-7. PubMed ID: 310850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells from lymphoepithelial thymoma produce a biochemical variant of IL-2.
    Cornaglia-Ferraris P; Ponzoni M
    Lymphokine Res; 1985; 4(3):251-63. PubMed ID: 3875768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyme disease spirochetes induce human and murine interleukin 1 production.
    Habicht GS; Beck G; Benach JL; Coleman JL; Leichtling KD
    J Immunol; 1985 May; 134(5):3147-54. PubMed ID: 2984284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.